Top Industry Leaders in the Orthobiologics Market
Jan 2024Zimmer Biomet (US) Launched their Vitoss® Bone Marrow Aspirate Concentrate (BMAC) system, an advanced platform for collecting and concentrating BMAC for use in orthopedic surgery.Partnered with research institutions to explore the potential of combining BMAC with other regenerative therapies for enhanced cartilage repair.
Exactech Received FDA approval for their Optec® Nano DBM putty, a next-generation bone graft substitute offering improved handling and injectability for surgeons.Invested in developing synthetic bone graft options, aiming to overcome challenges associated with donor tissue harvesting and potential disease transmission.
Acelity (US) Expanded their portfolio with the acquisition of a company specializing in PRP (platelet-rich plasma) technology, further strengthening their presence in the regenerative medicine market.Focused on developing evidence-based protocols for PRP use in specific orthopedic applications to optimize treatment efficacy.
Orthofix Medical Launched their Regenica® regenerative tissue matrix, a bioabsorbable collagen scaffold designed to promote natural tissue regeneration in soft tissue injuries.Collaborated with sports medicine teams to explore the use of Regenica for faster recovery and return to play for athletes.
International Society for Cellular Therapy (ISCT) Released updated guidelines for the safe and effective use of cell-based therapies in sports medicine and other orthopedic applications.Advocated for rigorous research and clinical trials to ensure the efficacy and safety of cell-based orthobiologics before widespread adoption.
List of Orthobiologics Key Companies in The Market
- Arthrex Inc
- Exactech Inc
- Globus Medical Inc
- Integra LifeSciences
- Johnson & Johnson
- Medline Industries Inc
- NuVasive Inc
- Stryker Corporation
- Wright Medical Group N.V.
- Zimmer Biomet